SCF-KIT Pathway in Human Epidermal Melanocyte Homeostasis
Open Access
- 1 July 1999
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 113 (1) , 139-40
- https://doi.org/10.1046/j.1523-1747.1999.00643.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The SCF/KIT Pathway Plays a Critical Role in the Control of Normal Human Melanocyte HomeostasisJournal of Investigative Dermatology, 1998
- Murine Cutaneous Mastocytosis and Epidermal Melanocytosis Induced by Keratinocyte Expression of Transgenic Stem Cell FactorThe Journal of Experimental Medicine, 1998
- Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo.The Journal of Experimental Medicine, 1996
- KIT Expression Reveals a Population of Precursor Melanocytes in Human SkinJournal of Investigative Dermatology, 1996
- Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patientsJournal of the American Academy of Dermatology, 1995
- Expression of stem cell factor in cutaneous mastocytosisBritish Journal of Dermatology, 1995
- Altered Metabolism of Mast-Cell Growth Factor (c-kit Ligand) in Cutaneous MastocytosisNew England Journal of Medicine, 1993
- Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor.Proceedings of the National Academy of Sciences, 1992
- Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble formsCell, 1990
- Histochemical survey of the distribution of the epidermal melanoblasts and melanocytes in the mouse during fetal and postnatal periodsThe Anatomical Record, 1984